Erik Waldorff, PhD Appointed New Director of Science & Innovation of Telos Partners

October 29, 2020

Erik Waldorff, Ph.D. is a new addition to Telos Partners LLC, a subsidiary of OrthoPediatrics Corp. (NASDAQ: KIDS) specializing in the strategic delivery of regulatory, reimbursement, and clinician adoption services to the musculoskeletal and wound care industries.

Erik Waldorff, Ph.D. will serve as Director, Science & Innovation, and will lead the Telos scientific services to lay the foundations of evidence necessary to meet medical device and biotechnology commercialization objectives.

Dr. Waldorff joins Telos with over 17 years of experience in pre-clinical and clinical scientific initiatives that underpinned the success of multiple orthopedic, spine, and neuromodulation medical devices. With a Ph.D. in Biomedical Engineering from the University of Michigan and currently completing coursework from the Carlson School of Management at the University of Minnesota, Dr. Waldorff brings the unique mix of technical leadership and business acumen that is essential for demonstrating value through evidence.

“Erik adds a wealth of experience and innovative thinking to strengthen the Telos scientific service offerings in our core areas of orthopedic and spine medical devices,” said Jason Inzana, General Manager of Telos. “From the first conversation, it was clear that he embodies the Telos approach to weave the technical details into the greater framework of the overall business objectives, which is a recipe for success both for Telos and our client partners. I’m excited to see the scientific services grow and thrive under Erik’s leadership.”

Dr. Waldorff added, “I am excited to be joining a very talented group at Telos and look forward to leveraging our collaborative expertise to support the growth potential of our clients.”

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr A Burton Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
John Taylor brings more than 30 years of regulatory experience to his role at ELIQUENT, including a distinguished 20-year career at the U.S. Food and Drug Administration (FDA), where he served in multiple leadership positions, including as FDA’s Acting Deputy Principal Commissioner, FDA Counselor to the Commissioner, Acting Deputy Commissioner for Global Regulatory Operations and Policy, and Associate Commissioner for Regulatory Affairs.
Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version